Differentiation of rat ovary after treatment with Busulfan
Rateau, J.G.
Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 168(10-11): 1163-1167
1974
ISSN/ISBN: 0037-9026 PMID: 4283065 Document Number: 79168
Document emailed within 1 workday
Related Documents
Cervantes, F.; Rozman, C.; Nomdedeu, B.; Blade, J.; Montserrat, E. 1986: Chronic myeloid leukemia: comparison of monotherapy with busulfan with busulfan and vincristine and 6-mercaptopurine cycles Revista Clinica Espanola 178(1): 4-7Ghalie, R.; Reynolds, J.; Valentino, L.A.; Manson, S.; Korenblit, A.D.; Feingold, J.M.; Adler, S.S.; Pruett, J.; Kaizer, H. 1994: Busulfan-containing pre-transplant regimens for the treatment of solid tumors Bone Marrow Transplantation 14(3): 437-442
Saraux, H.; Lefrancois, A. 1977: Degenerative retinal conditions after treatment with Busulfan during pregnancy Klinische Monatsblatter für Augenheilkunde 170(6): 818-820
Fetissof, F.; Arbeille, B.; Lansac, J.; Lhuintre, Y. 1989: Malignant mesodermal mixed tumor of the ovary with neuro-ectodermic differentiation Annales de Pathologie 9(3): 204-208
Larrain, C.; Cruz, A.; Codoceo, V. 1984: Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases Revista Medica de Chile 112(9): 898-911
Presl, J. 1984: The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome Ceskoslovenska Gynekologie 49(2): 124-125
Williams, T.J.; Dockerty, M.B. 1976: Status of the contralateral ovary in encapsulated low grade malignant tumors of the ovary Surgery Gynecology and Obstetrics 143(5): 763-766
Tuppurainen, K.; Nousiainen, T.; Lahtinen, R. 1985: Busulfan and eye complications Duodecim; Laaketieteellinen Aikakauskirja 101(24): 2420-2422
Ganda, O.P.; Mangalik, A. 1973: Delayed toxic effect of busulfan on the marrow Journal of the Association of Physicians of India 21(6): 511-516
Gaulier, M.; Roux, C. 1970: Effect of Busulfan on the germinal line of the rat embryo Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(11): 2165-2170
Makeeva, S.A.; Kalinin, A.P.; Bogatyrev, O.P. 1988: Treatment of the sclerocystic ovary syndrome Sovetskaia Meditsina 8: 114-117
deMagalhaes-Silverman, M.; Bloom, E.J.; Donnenberg, A.; Lister, J.; Pincus, S.; Rybka, W.B.; Ball, E.D. 1996: Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies Bone Marrow Transplantation 17(3): 329-333
Kolarz, G.; Pietsehmann, H.; Regele, H. 1970: Lung changes under busulfan therapy in a case of chronic myelosis Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 113(5): 539-544
Léonard, A.; Deknudt, G. 1983: Comparison in vivo of the clastogenic properties of busulfan and cyclophosphamide Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 177(2): 239-242
Santos, G.W.; Tutschka, P.J. 1974: Effect of busulfan on antibody production and skin allograft survival in the rat Journal of the National Cancer Institute 53(6): 1775-1780
Uzuka, Y.; Saito, Y. 1991: Combination therapy of chronic myelogenous leukemia with busulfan and bestatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(4): 571-578
Bell, D.S.H. 2007: Treatment of infertility in the polycystic ovary syndrome New England Journal of Medicine 356(19): 1999-2000; Author Reply 2000-2001
Escudero, M.; Díaz-Rubio, E.; Vidart, J.A.; Martín, M.; Herraiz, M.A.; Hernández, A. 1990: Treatment of cancer of the ovary in advanced stages (IIi and IV) Revista Clinica Espanola 186(3): 134-140
Taketani, Y.; Ishikawa, H.; Kinoshita, T.; Mizuno, M. 1986: Polycystic ovary--classification and treatment by bromocriptine Nihon Sanka Fujinka Gakkai Zasshi 38(10): 1697-1701
Barbieri, R.L.; Gargiulo, A.R. 2004: Metformin for the treatment of the polycystic ovary syndrome Minerva Ginecologica 56(1): 63-79